Skip to main content
SpringerLink
Log in

Genetic Basis of Proportional Short Stature

  • Chapter
The Growth Hormone/Insulin-Like Growth Factor Axis During Development

Part of the book series: Advances in Experimental Medicine and Biology ((volume 567))

  • 1219 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. L.A. Pérez Jurado, J. Argente, J. Pozo, V. Barrios, M. Hernández and U. Francke, Molecular diagnosis and endocrine evaluation of a patient with a homozygous 7.0 kilobase (kb) deletion of the growth hormone gene cluster: Achievement of an outstanding response to biosynthetic GH therapy and evidence indicating that growth hormone-binding hormone is not regulated by GH. J Pediatr Endocrinol Metab, 10, 185–190 (1997).

    PubMed  Google Scholar 

  2. R. Lindsay, M. Feldkamp, D. Harris, J. Robertson and M. Rallison, Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr, 125, 29–35 (1994).

    PubMed  CAS  Google Scholar 

  3. J. Argente, L.A. Pérez-Jurado and J.F. Sotos, Molecular basis of pathological growth. J Endocrine Genet, 1, 179–210 (2000).

    CAS  Google Scholar 

  4. P.E. Mullis, A. Akinci, C. Kanaka and C.G. Brook, Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations. Ped Res, 31, 532–534 (1992).

    CAS  Google Scholar 

  5. H. Hirt, J. Kimelman, M.J. Birnbau, E.Y. Chen, P.H. Seeburg, N.L. Eberhardt and A. Barta, The human growth hormone gene locus: Structure, evolution and allelic variations. DNA, 6, 59–70 (1987).

    Article  PubMed  CAS  Google Scholar 

  6. G. Binder, Isolated growth hormone deficiency and the GH-1 gene: update 2002. Horm Res, 58, S2–6 (2002).

    Google Scholar 

  7. J.D. Cogan, J.A. Phillips III, N.A. Sakati, F. Frisch, E. Schoeber and D. Milner, Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J Clin Endocrinol Metab, 76, 1224–1228 (1993).

    PubMed  CAS  Google Scholar 

  8. A.M. Procter, J.A. Phillips III and D.N. Cooper, The molecular genetics of growth hormone deficiency. Hum Genet, 103, 255–272 (1998).

    PubMed  CAS  Google Scholar 

  9. S.C. Lin, C.R. Lin, I. Gukovsky, A.J. Lusis, P.E. Sawchenko and M.G. Rosenfeld, Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature, 364, 208–213 (1993).

    PubMed  CAS  Google Scholar 

  10. M.P. Wajnrajch, J.M. Gertner, M.D. Harbison, S.C. Chua and R.L. Leibel, Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet, 12, 88–90 (1996).

    PubMed  CAS  Google Scholar 

  11. M.P. Wajnrajch, J.M. Gertner, A.S. Sokoloff, I. Ten, M.D. Harbison, I. Netchine, H.G. Maheshwari, D.B. Goldstein, S. Amselem, G. Baumann and L.R. Leibel, Haplotype analysis of the growth hormone releasing hormone receptor locus in three apprently unrelated kindreds from the indian subcontinent with the identical mutation in the GHRH receptor. Am J Med Genet, 120A, 77–83 (2003).

    PubMed  Google Scholar 

  12. R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips III, A.H.O. Souza, R.G. Gondo, S.P.A. Toledo, M.M. Conceicao, M. Prince, H.G. Maheshwari, G. Baumann, M.A. Levine, Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocr Metab, 84, 917–923 (1999).

    PubMed  CAS  Google Scholar 

  13. R. Salvatori, M.H. Aguiar-Oliveira, L.V. Monte, L. Hedges, N.L. Santos, R.M. Pereira and J.A. Phillips, Detection of a recurring mutation in the human growth hormone-releasing hormone receptor gene. Clin Endocrinol (Oxf), 57, 77–80 (2002).

    CAS  Google Scholar 

  14. R. Salvatori, X. Fan, P.E. Mullis, A. Haile and M.A. Levine, Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. Mol Endocrinol, 16, 450–458 (2002).

    PubMed  CAS  Google Scholar 

  15. R. Salvatori, X. Fan, J.D. Veldhuis and R. Couch, Serum GH response to pharmacological stimuli and physical exercise in two siblings with two new inactivating mutations in the GH-releasing hormone receptor gene. Eur J Endocrinol, 147, 591–596 (2002).

    PubMed  CAS  Google Scholar 

  16. H.A. Oliveira, R. Salvatori, M.P. Krauss, C.R. Oliveira, P.R. Silva and M.H. Aguiar-Oliveira, Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene. Eur J Endocrinol, 148, 427–432 (2003).

    PubMed  CAS  Google Scholar 

  17. M. Carakushansky, A.J., Whatmore, P.E. Clayton, S.M. Shalet, H.K. Gleeson, D.A. Price, M.A. Levine and R. Salvatori, A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency. Eur J Endocrinol, 148, 25–30 (2003).

    PubMed  CAS  Google Scholar 

  18. L.A. Pérez Jurado, J.A. Phillips III and U. Francke, Exclusion of growth hormone-releasing hormone gene mutations in familial isolated growth hormone deficiency by linkage and single strand conformation analysis. J Clin Endocrinol Metab, 78, 622–628 (1994).

    PubMed  Google Scholar 

  19. F. Roelfsema, N.R. Biermasz, R.G. Veldman, J.D. Veldhuis, M. Frolich, W.H. Stovkis-Brantsma and J.M. Wit, Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab, 86, 2459–2464 (2001).

    PubMed  CAS  Google Scholar 

  20. B.D. Gaylinn, C. von Kap-Herr, W. Golden and M.O. Thorner, Assignment of the human growth hormone-releasing hormone receptor gene (GHRHR) to 7p14 by in situ hybridization. Genomics, 19, 193–195 (1994).

    PubMed  CAS  Google Scholar 

  21. J.D. Cogan, J.A. Phillips III, S.S. Schenkman, R.D.G. Milner and N. Sakati, Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein. J Clin Endocrinol Metab, 79, 1261–1265 (1994).

    PubMed  CAS  Google Scholar 

  22. H. Abdul-Latif, E. Leiberman, M.R. Brown, R. Carmi and J.S. Parks, Growth hormone deficiency type IB caused by cryptic splicing of the GH-1 gene. J Pediatr Endocrinol Metab, 13, 21–28 (2000).

    PubMed  CAS  Google Scholar 

  23. E. Leiberman, D. Pesler, R. Parvari, K. Elbedour, H. Abdul-Latif, M.R. Brown, J.S. Parks and R. Carmi, Short stature in carriers of recessive mutation causing familial isolated growth hormone deficiency. Am J Med Genet, 90, 188–192 (2000).

    PubMed  CAS  Google Scholar 

  24. J.A. Phillips III, Inherited defects in growth hormone synthesis and action. (Scriver CR, Beaudet AL, Sly WS, Valle D, eds.) The metabolic basis of inherited disease. 6a ed. New York: McGraw-Hill, 1989; 1965–1983.

    Google Scholar 

  25. R.C.C. Ryther, L.M. McGuinness, J.A. Phillips III, C.T. Moseley, C.B. Magoulas, I.C.A.F. Robinson and J.G. Patton, Disruption of exon definition produces a dominant negative growth hormone isoform that causes somatotroph death and IGHD II. Hum Genet, 113, 140–148 (2003).

    PubMed  CAS  Google Scholar 

  26. G. Binder, E. Keller, M. Mix, G.G. Massa, W.H. Stokvis-Brantsma, J.M. Wit and M.B. Ranke, Isolated GH deficiency with dominant inheritance: new mutations, new insights. J Clin Endocrinol Metab, 86, 3877–3881 (2001).

    PubMed  CAS  Google Scholar 

  27. J. Deladoey, P. Stocker and P.E. Mullis, Autosomal dominant GH deficiency due to an Arg 183His GH-1 gene mutation: clinical and molecular evidence of impaired regulated GH secretion. J Clin Endocrinol Metab, 86, 3941–3947 (2001).

    PubMed  CAS  Google Scholar 

  28. D.S. Miller, M.D. Lewis, M. Horan, V. Newsway, T.E. Easter, J.W. Gregory, L. Fryklund, M. Norin, E.C. Crowne, S.J. Davies, P. Edwards, J. Kirk, K. Waldron, P.J. Smith, J.A. Phillips III, M.F. Scanlon, M. Krawczak, D.N. Cooper and A.M. Proctor. Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature. Hum Mutat, 21, 424–440 (2003).

    Google Scholar 

  29. T.A. Fleisher, R.M. White, S. Broder, S.P., Nissley, R.M. Blaese, J.J. Mulvihill, G.Y. Olive and T.A. Waldmann, X-linked hypogammaglobulinemia and isolate growth hormone deficiency. N Engl J Med, 302, 1429–1434 (1980).

    Article  PubMed  CAS  Google Scholar 

  30. M.E. Conley, A.W. Burks, H.G. Herrog and J.M. Puck, Molecular analysis of X-linked agammaglobulinemia with growth hormone deficiency. J Pediatr, 119, 392–397 (1992).

    Google Scholar 

  31. R. Rapaport, J. Oleske, H. Ahdieh, S. Solomon and S. Delfaus, Suppresion of immune function in growth hormone deficient children during treatment with human growth hormone. J Pediatr, 109, 434–439 (1993).

    Google Scholar 

  32. T. Ogata, C. Petit, G. Rappold, N. Matsuo, T. Matsumoto and P. Goodfellow, Chromosomal localization of (a) pseudoautosomal growth gene(s). J Med Genet, 29, 624–628 (1992).

    PubMed  CAS  Google Scholar 

  33. B. Duriez, P. Duquesnoy, F. Dastot, P. Bougneres, S. Amselem and M. Goossens, An exon-skipping mutation in the btk gene of a patient with X.linked agammaglobulinemia and isolated growth hormone deficiency. FEBS Lett, 346, 165–170 (1994).

    PubMed  CAS  Google Scholar 

  34. K. Abo, H. Nishio, M.J. Lee, D. Tsuzuki, T. Takahashi, S. Yoshida, T. Nakajima, M. Matsuo and K. Sumino, A novel single basepair insertion in exon 6 of the Bruton’s tyrosine kinase (Btk) gene from a Japanese X-linked agammaglobulinemia patient with growth hormone insufficiency. Hum Mutat, 11, 336 (1998).

    PubMed  CAS  Google Scholar 

  35. Y. Yokohama, K. Narahara, K. Tsuji, et al. Growth hormone deficiency and empty sella syndrome in a boy with dup(X)(q13.3–q21.2). Am J Med Genet, 42, 660–664 (1992).

    Google Scholar 

  36. M. Giordano, C. Marchetti, E. Chiorboli, G. Bona and P.M. Richiardi, Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene. Hum Genet, 100, 249–255 (1997).

    PubMed  CAS  Google Scholar 

  37. J.K. Wagner, A. Eblé, J.D. Cogan, M.A. Prince, J.A. Phillips and P.E. Mullis, Allelic variations in the human growth hormone-1 gene promoter of growth hormone-deficient patients and normal controls. Eur J Endocrinol, 137, 474–481 (1997).

    PubMed  CAS  Google Scholar 

  38. M. Horan, D.S. Miller, J. Hedderich, G. Lewis, V. Newsah, N. Mo, L. Fryklund, A.M. Procter, M. Krawczak and D.N. Cooper, Human growth hormone 1 (GH1) gene expression: Complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region. Hum Mutat, 21, 408–423 (2003).

    PubMed  CAS  Google Scholar 

  39. B.K. Jones, B.R. Monks, S.A. Liebhaber and N.E. Cooke, The human growth hormone gene is regulated by a multi-component locus control region. Mol Cell Biol, 15, 7010–7021 (1995).

    PubMed  CAS  Google Scholar 

  40. T. Su, S.A. Liebhaber and N.E. Cooke, The human growth hormone gene cluster locus control region supports position-independent pituitary-and placenta-specific expression in the transgenic mouse. J Biol Chem, 275, 7902–7909 (2000).

    PubMed  CAS  Google Scholar 

  41. Y. Ho, E. Elefant, N. Cooke and S. Liebhaber, A defined locus control region determinant links chromatin domain acetylation with long-range gene activation. Mol Cell, 9, 291–302 (2002).

    PubMed  CAS  Google Scholar 

  42. F.P. Lemaigre, B. Peers, D.A. Lafontaine, M. May-Hartert, G.G. Rousseau, A. Belayew and J.A. Martial, Pituitary-specific factor binding to the human prolactin, growth hormone and placental lactogen genes. DNA, 8, 149–159 (1989).

    PubMed  CAS  Google Scholar 

  43. Y. Jin, R.M. Surabhi, F. Fresnoza, A. Lytras and P.A. Cattin, A role for A/T-rich sequences and Pit-l/GHF-1 in a distal enhancer located in the human growth hormone locus control region with preferential pituitary activity in culture and transgenic mice. Mol Endocrinol, 13, 1249–1266 (1999).

    PubMed  CAS  Google Scholar 

  44. B.M. Shewchuk, S.L. Asa, N.E. Cooke and S.A. Liebhaber, Pit-1 binding sites at the somatotrope-specific DNase 1 hypersensitive sites I, II of the human growth locus control region are essential for in vivo hGH-N gene activation. J Biol Chem, 274, 35725–35733 (1999).

    PubMed  CAS  Google Scholar 

  45. B.M. Shewchuk, S.A. Liebhaber and N.E. Cooke, Specification of unique Pit-1 activity in the hGH locus control region. Proc Natl Acad Sci USA, 99, 11784–11789 (2002).

    PubMed  CAS  Google Scholar 

  46. A.A. Kowarski, J. Schneider, E. Ben-Galim, V.V. Weldon and W.H. Daughaday, Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab, 47, 461–464 (1978).

    Article  PubMed  CAS  Google Scholar 

  47. Y. Takahashi, H. Kaji, Y. Okinura, K. Goji, H. Abe and K. Chihara, Short stature caused by a mutant growth hormone with an antagonistic effect. New Engl J Med, 334, 432–436 (1996).

    PubMed  CAS  Google Scholar 

  48. Y. Takahashi, H. Shirono, O. Arisaka, K. Takahashi, T. Yagi, J. Koga, H. Kaji, Y. Okinura, H. Abe, T. Tanaka and K. Chihara K. Biologically inactive growth hormone caused by amino acid substitution. J Clin Invest, 100, 1159–1165 (1997).

    PubMed  CAS  Google Scholar 

  49. M.D. Lewis, M. Horan, D.S. Millar, V. Newsway, T.E. Easter, L. Fryklund, J.W. Gregory, M. Norin, C.J. Del Valle. J.P. López-Siguero, R. Cañete, L.F. Lopez-Canti, N. Díaz-Torrado, R. Espino, A. Ulied, M.F. Scanlon, A.M. Procter and D.N. Cooper, A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. J Clin Endocrinol Metab, 89, 1068–1075 (2004).

    PubMed  CAS  Google Scholar 

  50. J.S. Parks, M.R. Brown, D.L. Hurley, C.J. Phelps and M.P. Wajnrajch, Heritable disorders of pituitary development. J Clin Endocrinol Metab, 84, 4362–4370 (1999).

    PubMed  CAS  Google Scholar 

  51. P.E. Mullis, Transcription factors in pituitary gland development and their clinical impact on phenotype. Horm Res, 54, 107–119 (2000).

    PubMed  CAS  Google Scholar 

  52. B.I. Hendriks-Stegeman, K.D. Augustijn, B. Bakker, P. Holthuizen, P.C. van der Vliet and M. Jansen, Combined pituitary hormone deficiency caused by compound heterozygosity for two novel mutations in the POU domain of the Pitl/POU1FI gene. J Clin Endocrinol Metab, 86, 1545–1550 (2001).

    PubMed  CAS  Google Scholar 

  53. M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O’Connell, I. Gukovsky, C. Carriere, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.G. Beamer and M.G. Rosenfeld, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature, 384, 327–333 (1996).

    PubMed  CAS  Google Scholar 

  54. R.W. Pfaffle, G. DiMattia, J.S. Parks, M.R. Brown, J.M. Wit, M. Jansen, H. Van der Nat, J.L. Van en Brande, M.G. Rosenfeld and H.A. Ingraham, Mutation of the POU-specific domain of Pit-1 as a cause of hypopituitarism without pituitary hypoplasia. Science, 257, 1118–1121 (1992).

    PubMed  CAS  Google Scholar 

  55. K. Ohta, Y. Nobukuni, H. Mitsubuchi, T. Ohta, T. Tohma, Y. Jinno, F. Endo and I. Matsuda, Characterization of the gene encoding human pituitary-specific transcription factor, Pit-1. Gene, 122, 387–388 (1992).

    PubMed  CAS  Google Scholar 

  56. L.E. Theill and M. Karin, Transcriptional control of GH expression and anterior pituitary development. Endocr Rev, 14, 670–689 (1993).

    PubMed  CAS  Google Scholar 

  57. M. Bodner, J.L. Castrillo, L. Theill, T. Deernick, M. Ellisman and M. Karin, The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell, 55, 508–518 (1988).

    Google Scholar 

  58. H.A. Ingraham, R. Chen, H.J. Mangalam, H.P. Elsholtz, S.E. Flynn, C.R. Lin, D.M. Simmons, L. Swanson and M.G. Rosenfeld, A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell, 55, 519–529 (1988).

    PubMed  CAS  Google Scholar 

  59. R.W. Pfäffle, C. Kim, B. Otten, J.M. Wit, U. Eiholzer, G. Heimann and J. Parks, Pit-1: Clinical aspects. Horm Res, 45, S25–28 (1996).

    Google Scholar 

  60. K. Tatsumi, K. Miyai, T. Notomi, K. Kaibe, N. Amino, Y. Mizuno and H. Kohno, Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet, 1, 56–58 (1992).

    PubMed  CAS  Google Scholar 

  61. S. Radowick, M. Nations, Y. Du, L.A. Berg, B.D. Weintraub and F.E. Wondirsford FE, A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science, 257, 1115–1118 (1992).

    Google Scholar 

  62. N. Okamoto, Y. Wada, S. Ida, R. Koga, K. Ozono, H. Chiyo, A. Hayashi and K. Tatsumi, Monoallelic expression of normal mRNA in the PIT1 mutation heterozygotes with normal phenotype and biallelic expression in the abnormal phenotype. Hum Mol Genet, 3, 1565–1568 (1994).

    PubMed  CAS  Google Scholar 

  63. S. Mody, M.R. Brown and J.S. Parks, The spectrum of hypopituitarism caused by PROP1 mutations. Best Practice & Research in Clin Endocrinol Metab, 16, 421–431 (2002).

    CAS  Google Scholar 

  64. W. Wu, J.D. Cogan, R.W. Pfäffle, J.S. Dasen, H. Frisch, M.O. O’Connell, S.E. Flynn, M.R. Brown, P.E. Mullis, J.S. Parks, J.A. Philips III and M.G. Rosenfeld, Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet, 18, 147–149 (1998).

    PubMed  CAS  Google Scholar 

  65. G. Agarwal, V. Bathia, S. Cook and P.Q. Thomas, Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 mutation. J Clin Endocrinol Metab, 85, 4556–4561 (2000).

    PubMed  CAS  Google Scholar 

  66. F. Pernasetti, S.P.A. Toled, V.V. Vasilyev, C.Y. Hayashida, J.D. Cogan, C. Ferrari, D.M. Lourenco and P.M. Mellon, Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two base pair deletion (301–302delAG) in the Prophet of Pit-1 gene. J Clin Endocrinol Metab, 85, 390–397 (2000).

    PubMed  CAS  Google Scholar 

  67. J.D. Cogan, W. Wu, J.A. Phillips III, J.P.A. Ivo, A. Agapito, O.V. Fofanova, M.G.F. Osorio, I. Birgan, A. Moreno and B.B. Mendonca, The Propl 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab, 83, 3346–3349 (1998).

    PubMed  CAS  Google Scholar 

  68. S. Schmitt, A. Biason-Lauber, D. Betts and E.J. Schoenle, Genomic structure, chromosomal localisation, and expression pattern of the human LIM-homeobox3 (LHX3) gene. Biochem Biophys Res Commun, 274, 49–56 (2000).

    PubMed  CAS  Google Scholar 

  69. I. Netchine, M.L. Sobrier, H. Krude, D. Schnabel, M. Maghnie, E. Marcos, B. Duriez, V. Cacheux, A. Moers, M. Goossens, A. Grüters and S. Amselem, Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet, 25, 182–186 (2000).

    PubMed  CAS  Google Scholar 

  70. H.Z. Sheng, A.B. Zhadanov, B. Mosinger Jr, T. Fujii, S. Bertuzzi, A. Gringberg, E.J. Lee. S.P. Huang, K.A. Mahon and H. Westphal, Specification of pituitary cell lineages by LIM homeobox gene Lhx3. Science, 272, 1004–1007 (1996).

    PubMed  CAS  Google Scholar 

  71. H.Z. Sheng, K. Moriyama, T. Yamashita, H. Li, S.S. Potter, K.A. Mahon and H. Westphal, Multistep control of pituitary organogenesis. Science, 278, 1809–1812 (1997).

    PubMed  CAS  Google Scholar 

  72. K. Machinis, J. Pantel, I. Netchine, J. Léger, O.J.A. Camand, M.L. Sobrier, F. Dastot-Le Moal, P. Duquesnoy, M. Abibtol, P. Czernichow and S. Amselem, Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet, 69, 961–968 (2001).

    PubMed  CAS  Google Scholar 

  73. E. Hermesz, S. Mackem and K.A. Mahon, Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate, and Rathke’s pouch of the mouse embryo. Development, 122, 41–52 (1996).

    PubMed  CAS  Google Scholar 

  74. M.T. Dattani, J.P. Martiez-Barbara, P.Q. Thomas, J.M. Brickman, R. Gupta, I.L. Martensson, H. Toresson, M. Fox, J.K.H. Wales, P.C. Hindmarsh, S. Krauss, R.S.P. Beddington and I.C.A.F. Robinson, Mutations in the homeobox gene HESXl/Hesxl associated with septo-optic dysplasia in human and mouse. Nat Genet, 19, 125–133 (1998).

    PubMed  CAS  Google Scholar 

  75. G. de Morsier, Etudes sur les dysraphies cranio-encephaliques: III: Agenesie du septum lucidum avec malformation du tractus optique: La dysplasie septo-optique. Schweizer Arch. Neurol. Psychiatr, 77, 267–292 (1956).

    Google Scholar 

  76. S.A. Arslanian, W.E. Rothfus, T.P. Foley Jr and D.J. Becker, Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia. Acta Endocrinol (Copenh), 107, 282–288 (1984).

    CAS  Google Scholar 

  77. N. Izenberg, M. Rosenblum and J.S. Parks, The endocrine spectrum of septo-optic dysplasia. Clin Pediatr (Phila), 23, 632–636 (1984).

    Article  CAS  Google Scholar 

  78. U. Roessmann, Septo-optic dysplais or DeMorsier syndrome. J Clin Neuroophthalmol, 9, 156–159 (1989).

    PubMed  CAS  Google Scholar 

  79. J.M. Brickman, M. Clements, R. Tyrell, D. McNay, K. Woods, J. Warner, A. Stewart, R.S. Beddington and M. Dattani, Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development, 128, 5189–5199 (2001).

    PubMed  CAS  Google Scholar 

  80. P.Q. Thomas, M.T. Dattani, J.M. Brickman, D. McNay, G. Warne, M. Zacharin, F. Cameron, J.K. Hurst, K. Woods, D. Dunger, R. Stanhope, S. Forrest, I.C.A.F. Robinson and R.S.P. Beddington, Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet, 10, 39–45 (2001).

    PubMed  CAS  Google Scholar 

  81. L.R. Carvalho, K.S. Woods, B.B. Mendonca, N. Marcal, A.L. Zamparini, S. Stifani, J.M. Brickman, I.J. Arnhold and M.T. Dattani, A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J Clin Invest, 112, 1192–1201 (2003).

    PubMed  CAS  Google Scholar 

  82. T. Tajima, T. Hattorri, T. Nakajima, K. Okuhara, K. Sato, S. Abe, J. Nakae and K. Fujieda, Sporadic heterozygous frameshift mutation in HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab, 88, 45–50 (2003).

    PubMed  CAS  Google Scholar 

  83. R.N. Cohen, L.E. Cohen, D. Botero, C. Yu, A. Sagar, M. Jurkiewicz and S. Radovick, Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab, 8, 4832–4839 (2003).

    Google Scholar 

  84. Z. Laron, A. Pertzelan and S. Mannheimer, Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sci, 2, 152–155 (1966).

    PubMed  CAS  Google Scholar 

  85. Z. Laron, A. Pertzelan and M. Karp, Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci, 4, 883–894 (1968).

    PubMed  CAS  Google Scholar 

  86. A. Pertzelan, A. Adam and Z. Laron, Genetic aspects of pituitary dwarfism due to absence of biological activity of growth hormone. Isr J Med Sci, 4, 895–900 (1968).

    PubMed  CAS  Google Scholar 

  87. Z. Laron, P. Lilos and B. Klinger, Growth curves for Laron syndrome. Arch Dis Child, 68, 768–770 (1993).

    PubMed  CAS  Google Scholar 

  88. R.G. Rosenfeld, A.L. Rosenbloom and J. Guevara-Aguirre, Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev, 15, 369–390 (1994).

    PubMed  CAS  Google Scholar 

  89. K.A. Woods, F. Dastot, M.A. Perece, A.J. Clark, M.C. Postel-Vinay, P.G. Chatelain, M.B. Ranke, R.G. Rosenfeld, S. Amselem and M.O. Savage, Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab, 82, 3529–3535 (1997).

    PubMed  CAS  Google Scholar 

  90. R. Eshet, Z. Laron, A. Pertzelan and M. Dintzman, Defect of human growth hormone in the liver of two patients with Laron type dwarfism. Isr J Med Sci, 20, 8–11 (1984).

    PubMed  CAS  Google Scholar 

  91. D.E. Barton, B.E. Foellmer, W.I. Woods and U. Francke, Chromosome mapping of the growth hormone receptor gene in man and mouse. Cytogenet Cell Genet, 50, 137–141 (1989).

    Article  PubMed  CAS  Google Scholar 

  92. Z. Laron, Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958–2003. J Clin Endocrinol Metab, 89, 1031–1044 (2004).

    PubMed  CAS  Google Scholar 

  93. J. Wojcik, M.A. Berg, N. Esposito, M.E. Geffner, N. Sakati, E.O. Reiter, S. Dower, U. Francke, M.C. Postel-Vinay and J. Finidori, Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor. J Clin Endocrinol Metab, 83, 4481–4489 (1998).

    PubMed  CAS  Google Scholar 

  94. J. Gent, M. Van den Eijnden, P. Van Kerkhof and G.J. Strous, Dimerization and signal transduction of the growth hormone receptor. Mol Endocrinol, 17, 967–975 (2003).

    PubMed  CAS  Google Scholar 

  95. K.A. Woods, N.C. Fraser, M.C. Postel-Vinay, M.O. Savage and A.J. Clark, A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab, 81, 1686–1690 (1996).

    PubMed  CAS  Google Scholar 

  96. H. Kaji, O. Nose, H. Tajiri, Y. Takahashi, K. Iida, T. Takahashi, Y. Okimura, H. Abe and K. Chihara, Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. J Clin Endocrinol Metab, 82, 3705–3709 (1997).

    PubMed  CAS  Google Scholar 

  97. R.M. Ayling, R. Ross, P. Towner, S. Von Laue, J. Finidori, S. Moutoussamy, C.R. Buchanan, P.E. Clayton and M.R. Norman, A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet, 16, 13–14 (1997).

    PubMed  CAS  Google Scholar 

  98. K. Iida, Y. Takahashi, H. Kaji, O. Nose, Y. Okimura, H. Abe and K. Chihara, Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain. J Clin Endocrinol Metab, 83, 531–537 (1998).

    PubMed  CAS  Google Scholar 

  99. J.M. Gastier, M.A. Berg, P. Vesterhus, E.O. Reiter U. Francke, Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome. Hum Mutat, 16, 323–333 (2000).

    PubMed  CAS  Google Scholar 

  100. P.J. Godowski, D.W. Leung, L.R. Meacham, J.P. Galgani, R. Hellmiss, R. Keret, P.S. Rotwein, J.S. Parks, Z. Laron and W.I. Wood, Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA, 86, 8083–8087 (1989).

    PubMed  CAS  Google Scholar 

  101. J.A. Wells, Binding in the growth hormone receptor complex. Proc Natl Acad Sci USA, 93, 1–6 (1996).

    PubMed  CAS  Google Scholar 

  102. L.S. Argetsinger, G.S. Campbell, X. Yang, B.A. Witthuhn, O. Silvennoinen, J.N. Ihle and C. Carter-Su. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell, 74, 237–244 (1993).

    PubMed  CAS  Google Scholar 

  103. P. Colosi, K. Wong, S.R. Leong and W.I. Wood, Mutational analysis of the intracellular domain of the human growth hormone receptor. J Biol Chem, 268, 12617–12623 (1993).

    PubMed  CAS  Google Scholar 

  104. U.D. Wang and W.I. Wood, Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signalling. Mol Endocrinol, 9, 303–311 (1995).

    PubMed  CAS  Google Scholar 

  105. L.A. Winston and P.J. Bertics, Growth hormone stimulates the tyrosine phosphorylation of 42-and 45-kDa ERK-related proteins. J Biol Chem, 267, 4747–4751 (1992).

    PubMed  CAS  Google Scholar 

  106. T. Zhu and P.E. Lobie, Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone. Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis. J Biol Chem, 2375, 2103–2114 (2000).

    Google Scholar 

  107. T. Zhu, E.I. Goh, D. LeRoith and P.E. Lobie, Growth hormone stimulates the formation of a multiprotein signalling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem, 273, 33861–33875 (1998).

    Google Scholar 

  108. J. Herrington and C. Carter-Su, Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab, 12, 252–257 (2001).

    PubMed  CAS  Google Scholar 

  109. W.H. Daughaday, Are there direct, non-IGF-I-mediated effects of hGH? in Lessons from Laron Syndrome (LS) 1966–1992. In: Pediatric and Adolescent Endocrinology, vol. 24, Z. Laron and J.S. Parks, Eds, Basel-New York (1993).

    Google Scholar 

  110. P.A. Kelly, L. Goujon, A. Sotiropoulos, H. Dinerstein, N. Esposito, M. Edery, J. Finidori and M.C. Postel-Vinay, The GH receptor and signal transduction. Horm Res, 42, 133–139 (1994).

    Article  PubMed  CAS  Google Scholar 

  111. A. Sotiropoulos, S. Moutoussamy, F. Renaudie, M. Clauss, C. Kayser, F. Gouilleux, P.A. Kelly and J. Finidori, Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol Endocrinol, 10, 998–1009 (1996).

    PubMed  CAS  Google Scholar 

  112. A. Milward, L. Metherell, M. Mamara, M.J. Barahona, I.R. Wilkinson, C. Camacho-Hübner, M.O. Savage, C.M. Bidlingmaier, A.J.L. Clark, R.J.M. Ross and S.M. Webb, Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Boxl, resulting in isolated failure of STAT5 signal transduction. J Clin Endocrinol Metab, 89, 1259–1266 (2004).

    PubMed  CAS  Google Scholar 

  113. E.M. Kofoed, V. Hwa, B. Little, K.A. Woods, C.K. Buckway, J. Tsubaki, K.L. Pratt, L. Bezrodnik, H. Jasper, A. Tepper, J.J. Heinrich and R.G. Rosenfeld, Growth hormone insensitivity associated with a STAT5b mutation. N Eng J Med, 349, 1139–1147 (2003).

    CAS  Google Scholar 

  114. S.L. Chew, P. Lavender, A.J. Clark and R.J. Ross, An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology, 136, 1939–1944 (1995).

    PubMed  CAS  Google Scholar 

  115. M. Jansen, F.M. van Schaik, A.T. Ricker, B. Bullock, D.E. Woods, K.H. Gabbay, A.L. Nussbaum, J.S. Sussenbach and J.L. Van den Brande, Sequence of cDNA encoding human insulin-like growth factor I Precursor. Nature, 306, 609–611 (1983).

    PubMed  CAS  Google Scholar 

  116. L.B. Rall, J. Scott and G.I. Bell, Human insulin-like growth factor I and II messenger RNA: isolation of complementary DNA and analysis of expression. Meth Enzymol, 146, 239–248 (1987).

    PubMed  CAS  Google Scholar 

  117. P.H. Steenbergh, A.M. Koonen-Reemst, C.B. Cleutjens and J.S. Sussenbach, Complete nucleotide sequence of the high molecular weight human IGF-I mRNA. Biochem Biophys Res Commun, 175, 507–514 (1997).

    Google Scholar 

  118. P. Rotwein, Two insulin-like growth factor I messenger RNAs are expressed in human liver. Proc Natl Acad Sci USA, 83, 77–81 (1986).

    PubMed  CAS  Google Scholar 

  119. P. Rotwein, Molecular Biology of IGF-I and IGF-II. In: The IGF system: Molecular Biology, Physiology and clinical applications. R.G. Rosenfeld and C.T. Roberts Jr. Eds, Humana Press, Totowa NJ, (1999).

    Google Scholar 

  120. K.A. Woods, C. Camacho-Hubner, R.N. Bergma, D. Barter, A.J. Clark and M.O. Savage, Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab, 85, 1407–1411 (2000).

    PubMed  CAS  Google Scholar 

  121. S.K. Rasmussen, C. Lautier, L. Hansen, S.M. Echwald, T. Hansen, C.T. Ekstrom, S.A. Urhammer, K. Borch-Johnsen, F. Grigorescu, R.J. Smith and O. Pedersen, Studies of the variability of the genes encoding the insulin like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. J Clin Endocrinol Metab, 85, 1606–1610 (2000).

    PubMed  CAS  Google Scholar 

  122. A. Arends, H.J.J. Verhaar, E.H.F. De Haan, W.R. De Vries, M.M. Samson, M.L. Drent, E.A. Van Der Veen and H.P.F. Koppeschaar, Polymorphism in the IGF-1 gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab, 87, 2720–2724 (2002).

    PubMed  CAS  Google Scholar 

  123. G. Bauman, M.A. Shaw and T.J. Merimee, Low levels of high-affinity growth hormone-binding protein in African pygmies. N Engl J Med, 320, 1705–1709 (1989).

    Article  Google Scholar 

  124. T.J. Merimee, G. Baumann and W. Daughaday, Growth hormone-binding protein: II. Studies in pygmies and normal statured subjects. J Clin Endocrinol Metab, 71, 1183–1188 (1990).

    PubMed  CAS  Google Scholar 

  125. Y. Hattori, J.C. Vera, C.I. Rivas, N. Bersch, R.C. Bailey, M.E. Geffner and D.W. Golde, Decreased insulin-like growth factor I receptor expression and function in immortalized African Pygmy T cells. J Clin Endocrinol Metab, 81, 2257–2263 (1996).

    PubMed  CAS  Google Scholar 

  126. A.B. Cortez, C. Van Dop, R.C. Bailey, N. Bersch, M. Scott, D.W. Golde and M.E. Geffner, IGF-I resistance in virus transformed β-lymphocytes from African Efe pygmies. Biochem Mol Med, 58, 31–36 (1996).

    PubMed  CAS  Google Scholar 

  127. N. Davila, B.T. Shea, K. Omoto, M. Mercado, S. Misawa and G. Baumann, Growth hormone binding protein, insulin-like growth factor-I and short stature in two pygmy populations from the Philippines. J Pediatr Endocrinol Metab, 15, 269–276 (2002).

    PubMed  CAS  Google Scholar 

  128. J.R. Bierich, H. Moeller, M.B. Ranke and R.G. Rosenfeld, Pseudopituitary dwarfism due to resistance to somatomedin: A new syndrome. Eur J Pediat, 142, 186–188 (1984).

    CAS  Google Scholar 

  129. E. Heath-Monnig, H.J. Wohltmann, B. Mills-Dunlap W.H. Daughaday, Measurement of insulin-like growth factor I (IGF-I) responsiveness of fibroblasts of children with short stature: identification of a patient with IGF-I resistance. J Clin Endocrinol Metab, 64, 501–507 (1987).

    PubMed  CAS  Google Scholar 

  130. T. Momoi, C. Yamanaka, M. Kobayashi, T. Haruta, H. Sasaki, T. Yorifuji, M. Kaji and H. Mikawa, Short stature with normal growth hormone and elevated IGF-I. Eur J Pediatr, 151, 321–325 (1992).

    PubMed  CAS  Google Scholar 

  131. S.E. Tollefsen, E. Heath-Monnig, M.A. Cascieri, M.L. Bayne and W.H. Daughaday, Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-1 resistance in cultured fibroblasts from a patient with short stature. J Clin Invest, 87, 1241–1250 (1991).

    Article  PubMed  CAS  Google Scholar 

  132. A.M. Abbott, R. Bueno, M.T. Pedrini, J.M. Murray and R.J. Smith, Insulin-like growth factor I receptor gene structure. J Biol Chem, 267, 10759–10763 (1992).

    PubMed  CAS  Google Scholar 

  133. U. Francke, T.L. Yang.Feng, J.E. Brissenden and A. Ullrich, Chromosomal mapping of genes involved in growth control. Cold Spring Harbor Symp Quant Biol, 51, 855–866 (1986).

    PubMed  CAS  Google Scholar 

  134. M.J. Abuzzahab, A. Schneider, A. Goddard, F. Grigorescu, C. Lautier, E. Keller, W. Kiess, J. Klammt, J. Kratzsch, D. Osgood, R. Pfaffle, K. Raile, B. Seidel, R.J. Smith and S.D. Cherfnausek, IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Eng J Med, 349, 2211–2222 (2003).

    CAS  Google Scholar 

  135. A.J. D’Ercole, P. Ye, A.S. Calikoglu and G. Guitierez-Ospina, The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol, 13, 227–255 (1996).

    Google Scholar 

  136. R.C. Baxter, Circulating levels and molecular distribution of the acid-labile a-subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab, 70, 1347–1353 (1990).

    Article  PubMed  CAS  Google Scholar 

  137. R.C. Baxter, J.L. Martin V.A. Beniac, High molecular weight insulin-like growth factor binding protein complex: purification and properties of the acid-labile subunit from human serum. J Biol Chem, 264, 11843–11848 (1989).

    PubMed  CAS  Google Scholar 

  138. G.T. Ooi, F.J. Cohen, L.Y. Tseng, M.M. Rechler and Y.R. Boisclair, Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver. Mol Endocrinol, 11, 997–1007 (1997).

    PubMed  CAS  Google Scholar 

  139. H-P. Guler, J. Zapf, C. Schmid and E.R. Froesch, Insulin-like growth factors I and II in healthy man: estimations of half lives and production rates. Acta Endocrinol (Copenh), 121, 753–758 (1989).

    CAS  Google Scholar 

  140. S.R. Leong, R.C. Baxter, T. Camerato, J. Dai and W.I. Wood, Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex. Mol Endocrinol, 6, 870–876 (1992).

    PubMed  CAS  Google Scholar 

  141. I. Ueki, G.T. Ooi, M.L. Tremblay, K. Hurst, L.A. Bach and Y.R. Boisclair, Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Nat Acad Sci USA, 97, 6868–6873 (2000).

    PubMed  CAS  Google Scholar 

  142. H.M. Domené, S.V. Bengolea, A.S. Martínez, M.G. Ropelato, P. Pennisi, P. Scaglia, J.J. Heinrich and H.G. Jasper, Deficiency of the circulation insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Eng J Med, 350, 570–577 (2004).

    Google Scholar 

  143. A.A. Butler and D. LeRoith, Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology. Endocrinology, 142, 1685–1688 (2001).

    PubMed  CAS  Google Scholar 

  144. E. Rao, B. Weiss, M. Fukami, A. Rump, B. Niesler, A. Mertz, K. Muroya, G. Binder, S. Kirsch, M. Winkelmann, G. Nordsiek, U. Heinrich, M.H. Breuning, M.B. Ranke, A. Rosenthal, T. Ogata and G.A. Rappold, Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet, 16, 54–63 (1997).

    PubMed  CAS  Google Scholar 

  145. J.W. Ellison, Z. Wardak, M.F. Young, P.G. Robey, M. Laig-Webster and W. Chiong, PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet, 6, 1341–1347 (1997).

    PubMed  CAS  Google Scholar 

  146. V. Belin, C. Cusin, G. Viot, D. Girlich, A. Toutain, A. Moncla, M. Vekemans, M. Le Merrer, A. Munnich and V. Cormier-Daire, SHOX mutations in dyschondrosteosis (Léri-Weill syndrome). Nat Genet, 19, 67–69 (1998).

    PubMed  CAS  Google Scholar 

  147. D.J. Shears, H.J. Vassal, F.R. Goodman, R.W. Palmer, W. Reardon, A. Superti-Furga, P.J. Scambler and R.M. Winter, Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet, 19, 70–73 (1998).

    PubMed  CAS  Google Scholar 

  148. T. Kosho, K. Muroya, T. Nagai, M. Fujimoto, S. Yokoya, H. Sakamoto, T. Hirano, H. Teraskai, H. Ohashi, G. Nishimura, S. Sato, N. Matsuo and T. Ogata, Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab, 84, 4613–4621 (1999).

    PubMed  CAS  Google Scholar 

  149. M. Adachi, K. Tachibana, Y. Asakura, K. Muroya, T. Ogata, Del (X)(p21.1) in a mother and two daughters: genotype-phenotype correlation of Turner features. Hum Genet, 106, 306–10 (2000).

    PubMed  CAS  Google Scholar 

  150. M. Clement-Jones, S. Schiller, E. Rao, R.J. Blaschke, A. Zuniga, R. Zeller, S.C. Robson, G. Binder, I. Glass, T. Strachan, S. Lindsay and G.A. Rappold, The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet, 9, 695–702 (2000).

    PubMed  CAS  Google Scholar 

  151. A. Marchini, T. Marttila, A. Winter, S. Caldeira, I. Malanchi, R. Blaschke, B. Hacker, E. Rao, M. Karperien, J.M. Wit, W. Richter, M. Tommasinio and G. Rappold, The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J Biol Chem, 279, 37103–37114 (2004).

    PubMed  CAS  Google Scholar 

  152. F. Laumonnier, N. Ronce, B.C.J. Hamel, P. Thomas, J. Lespinasse, M. Raynaud, C. Paringaux, H. van Bokhoven, V. Kalscheuer, J.P. Fryns, J. Chelly, C. Moraine and S. Briault, Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet, 71, 1450–1455 (2002).

    PubMed  CAS  Google Scholar 

  153. N.M. Solomon, S. Nouri, G.L. Warne, M. Lagerstrom-Fermer, S.M. Forrest and P.Q. Thomas, Increased gene dosage at Xq26–q27 is associated with X-linked hypopituitarism. Genomics, 79, 553–559 (2002).

    PubMed  CAS  Google Scholar 

  154. J.E. Spence, R.G. Perciaccante, G.M. Greig, H.F. Willard, D.H. Ledbetter, J.F. Hejtmancik, M.S. Pollack, W.E. O’Brien and A.L. Beaudet, Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet, 42, 217–226 (1988).

    PubMed  CAS  Google Scholar 

  155. D. Kotzot, S. Schmitt, F. Bernasconi, W.P. Robinson, I.W. Lurie, H. Ilyina, K. Mehes, B.C.J. Hamel, B.J. Otten, M. Hergersberg, E. Werder, E. Schoenle and A. Schinzel, Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation. Hum Mol Genet, 4, 583–587 (1995).

    PubMed  CAS  Google Scholar 

  156. C.A. Joyce, A. Sharp, J.M. Walker, H. Bullman and I.K. Temple, Duplication of 7p12.1–p13, including GRB10 and IGFBP1, in a mother and daughter with features of Silver-Russell syndrome. Hum Genet, 105, 273–280 (1999).

    PubMed  CAS  Google Scholar 

  157. D. Monk, E.L. Wakeling, V. Proud, M. Hitchins, S.N. Abu-Amero, P. Stanier, M.A. Preece and G.E. Moore, Duplication of 7p11.2–p13, including GRB10, in Silver-Russell syndrome. Am J Hum Genet, 66, 36–46 (2000).

    PubMed  CAS  Google Scholar 

  158. N. Miyoshi, Y. Kuroiwa, T. Kohda, H. Shitara, H. Yonekawa, T. Kawabe, H. Hasegawa, S.C. Barton, M.A. Surani, T. Kaneko-Ishino and F. Ishino, Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene. Proc Nat Acad Sci USA, 95, 1102–1107 (1998).

    PubMed  CAS  Google Scholar 

  159. W. He, D.W. Rose, J.M. Olefsky and T.A. Gustafson, Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains. J Biol Chem, 273, 6860–6867 (1998).

    PubMed  CAS  Google Scholar 

  160. H. Yoshihashi, K. Maeyama, R. Kosaki, T. Ogata, M. Tsukahara, Y. Goto, J. Hata, N. Matsuo, R.J. Smith and K. Kosaki, Imprinting of human GRB10 and its mutations in two patients with Russell-Silver syndrome. Am J Hum Genet, 67, 476–482 (2000).

    PubMed  CAS  Google Scholar 

  161. K. Hannula, M. Lipsanen-Nyman, T. Kontiokari and J. Kere, A narrow segment of maternal uniparental disomy of chromosome 7q31-qter in Silver-Russell syndrome delimits a candidate gene region. Am J Hum Genet, 68, 247–253 (2001).

    PubMed  CAS  Google Scholar 

  162. M.P. Hitchins, D. Monk, G.M. Bell, Z. Ali, M.A. Preece, P. Stanier and G.E. Moore, Maternal repression of the human GRB10 gene in the developing central nervous system; evaluation of the role for GRB10 in Silver-Russell syndrome. Eur J Hum Genet, 9, 82–90 (2001).

    PubMed  CAS  Google Scholar 

  163. J.A. McCann, H. Zheng, A. Islam, C.G. Goodyer and C. Polychronakos, Evidence against GRB10 as the gene responsible for Silver-Russell syndrome. Biochem Biophys Res Commun, 286, 943–948 (2001).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital Infantil Universitario Niño Jesús. Department of Paediatric Endocrinology, Universidad Autónoma de Madrid, Spain

    Ángel Campos-Barros, Karen E. Heath & Jesús Argente

Authors
  1. Ángel Campos-Barros
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen E. Heath
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jesús Argente
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Instituto de Investigaciones Biomedicas “Alberto Sols” Consejo Superior de Investigaciones Cientificas (IIB-CSIC), Universidad Autonoma de Madrid (UAM), Arturo Duperier 4, 28029, Madrid, Spain

    Isabel Varela-Nieto PhD

  2. Department of Endocrinology and Investigation, Hospital Infantil Universitario Niño Jesús, Menéndez Pelayo, 65, 28009, Madrid, Spain

    Julie A. Chowen PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Campos-Barros, Á., Heath, K.E., Argente, J. (2005). Genetic Basis of Proportional Short Stature. In: Varela-Nieto, I., Chowen, J.A. (eds) The Growth Hormone/Insulin-Like Growth Factor Axis During Development. Advances in Experimental Medicine and Biology, vol 567. Springer, Boston, MA. https://doi.org/10.1007/0-387-26274-1_14

Download citation

  • DOI: https://doi.org/10.1007/0-387-26274-1_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25119-6

  • Online ISBN: 978-0-387-26274-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation